Rho GTPases control cytoskeletal dynamics through cytoplasmic effectors and regulate transcriptional activation through myocardin-related transcription factors (MRTFs), which are co-activators for serum response factor (SRF). We used RNA interference to investigate the contribution of the MRTF-SRF pathway to cytoskeletal dynamics in MDA-MB-231 breast carcinoma and B16F2 melanoma cells, in which basal MRTF-SRF activity is Rho-dependent. Depletion of MRTFs or SRF reduced cell adhesion, spreading, invasion and motility in culture, without affecting proliferation or inducing apoptosis. MRTF-depleted tumour cell xenografts showed reduced cell motility but proliferated normally. Tumour cells depleted of MRTF or SRF failed to colonize the lung from the bloodstream, being unable to persist after their arrival in the lung. Only a few genes show MRTFdependent expression in both cell lines. Two of these, MYH9 (NMHCIIa) and MYL9 (MLC2), are also required for invasion and lung colonization. Conversely, expression of activated MAL/MRTF-A increases lung colonization by poorly metastatic B16F0 cells. Actinbased cell behaviour and experimental metastasis thus require Rho-dependent nuclear signalling through the MRTF-SRF network.
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Rho GTPases control the dynamics of the cytoskeleton through multiple effector proteins that regulate the assembly, activity and turnover of actin-based structures, thereby controlling cell adhesion, morphology and motility [1] [2] [3] . Rho signalling, especially through RhoC and its effector kinase ROCK, is strongly implicated in cancer metastasis [4] [5] [6] [7] [8] , and this is generally thought to reflect direct effects on the cytoskeleton 2, 3 . In addition to the direct cytoplasmic role of Rho effectors in cytoskeletal regulation, Rho GTPases also control activity of MAL/MRTF-A and MKL2/MRTF-B (the MRTFs, myocardin-related transcription factors), which are transcriptional co-activators of the transcription factor SRF 9, 10 . Rho signalling controls MRTF activity by regulating the availability of G-actin, whose binding to the MRTF amino-terminal RPEL domain inhibits MRTF nuclear import, promotes MRTF nuclear export and inhibits activation by the MRTF-SRF complex [10] [11] [12] . In fibroblasts, both basal and growth factor-induced MRTF activity are dependent on functional Rho 9, 10 .
Many SRF target genes encode cytoskeletal components, including actin 13 . Control of MRTF activity by Rho thus potentially provides a mechanism by which cytoskeletal gene expression can be coordinated with cytoskeletal regulation. Indeed, SRF-null cells have defects in adhesion and migration 14, 15 , and MRTF signalling is required for fly border cell migration 16 and neuronal guidance in mouse forebrain 17 . However, the notion that transcriptional regulation through the Rho-actin-MRTF-SRF nuclear signalling pathway is required in addition to Rho-controlled cytoplasmic events for effective execution of cytoskeletal remodelling has remained untested. To address this issue directly and determine its significance for tumour metastasis, we studied the role of MRTF-SRF signalling in two highly metastatic tumour cell lines, human MDA-MB-231 breast carcinoma and mouse B16F2 melanoma cells. Rho and its effectors are required for invasion and migration in both cell lines 4, [18] [19] [20] [21] [22] . MDA-MB-231 cells express high levels of RhoA-GTP and metastasis of these cells, which requires RhoA and RhoC, is dependent on SDF1/CXCR4-induced actin polymerization [23] [24] [25] . Similarly, in vivo selection of the highly metastatic mouse B16F2 melanoma cell line resulted in increased expression of RhoC 4 .
RESULTS

MRTF and SRF activity is dependent on Rho-actin signalling in tumour cell lines
We first assessed the role of Rho-actin signalling to the MRTFs and SRF in the two tumour cell lines. MRTF proteins in MDA-MB-231 cells were predominantly nuclear even under resting conditions, and this was dependent on active Rho, whereas MRTFs in resting B16F2 cells were cytoplasmic and only accumulated in the nucleus on stimulation, as previously observed in other cells 10 (Fig. 1a ; see Discussion). In both cell types, however, the ability of MAL/MRTF-A to activate an SRF reporter gene was dependent on functional Rho, and was also inhibited by co-expression of the nonpolymerizable actin mutant R62D, and by latrunculin treatment (Fig. 1b) .
Mutationally activated forms of both RhoA and RhoC also activated the SRF reporter gene in both cell types (Fig. 1c ). MRTF and SRF activity is thus dependent on Rho-actin signalling in these cells.
We used RNA interference (RNAi) to deplete MRTF and SRF in the two cell lines. To activate the MRTF-SRF pathway, we used cytochalasin D, which disrupts MRTF association with G-actin 10, 12 , activating SRF reporter gene expression independently of functional Rho (Fig. 1d ). Cytochalasin D stimulation activated MRTF-SRF-dependent gene expression, as discussed further below. Cytochalasin D-stimulated reporter activity in MDA-MB-231 cells was partially inhibited by depletion of either MAL/ MRTF-A or MKL2/MRTF-B, whereas simultaneous depletion of both MRTFs, or depletion of SRF, reduced reporter activity to background levels ( Fig. 1e ). Reporter activation by activated Rho GTPases was also MRTF-dependent ( Fig. 1c ). Both MRTF proteins thus contribute to SRF reporter activity in these tumour cells, as observed in NIH3T3 fibroblasts 7 (S.M. and R.T., manuscript in preparation). We established subclones of MDA-MB-231 and B16F2 cells expressing tetracycline-inducible shR-NAs specific for MRTF and SRF ( Fig. 1f ; Supplementary Information, Fig. S1a, b). In both cell types, significant inhibition of SRF reporter activity was seen even in untreated cells, and this became virtually complete upon full shRNA induction by tetracycline ( Fig. 1f ; Supplementary  Information, Fig. S1a ).
Adhesion and spreading require MRTF-SRF activity
Adhesion of MDA-MB-231 cells to fibronectin or collagen matrices was significantly reduced on simultaneous depletion of both MRTFs or SRF in short-term depletion assays ( Fig. 2a , left). The stable MDA-MB-231 shRNA cells showed a mild impairment of adhesion 30 min after plating, and this was exacerbated by tetracycline treatment ( Fig. 2a ; Supplementary Information, Fig. 2 ). Three hours after plating, MDA-MB-231 control cells had spread efficiently on either matrix ( Fig. 2b ; Supplementary Information, Fig. S2 ), showing lamellar protusions, stress fibre-like actin bundles and punctate peripheral paxillin staining ( Fig. 2c ). In contrast, even in the absence of tetracycline, the MDA-MB-231 MRTF shRNA cells showed decreased spreading, with a reduction in punctate paxillin staining and stress fibres; on complete MRTF depletion, MDA-MB-231 cells remained rounded, and punctate paxillin staining and F-actin bundles were effectively absent at 3 h ( Fig. 2b, c) . These phenotypes were transient and the cells assumed a fully spread morphology by 10 h after plating (data not shown). SRFdepleted cells showed similar behaviour, consistent with the notion that SRF mediates MRTF activity ( Fig. 2d ). In B16F2 cells, MRTF depletion also impaired cell spreading ( Fig. 2e ). 
MRTF-SRF signalling is required for cell motility
We used the scratch-wound assay to assess the requirement for MRTF-SRF signalling in cell motility. Short-term depletion of both MRTFs from MDA-MB-231 cells caused a marked decrease in cell speed ( Fig. 3a) . Similar results were obtained with the stable MDA-MB-231 MRTF shRNA cells and also in B16F2 Mrtf shRNA cells ( Fig. 3b , c, e). Consistent with MRTFs acting through SRF, depletion of SRF, both in short-term assays in MDA-MB-231 cells and in stable SRF shRNA clones, also lowered migration speed ( Fig. 3a, d, e ). The cell lines showed different sensitivity to MRTF depletion: in MDA-MB-231 15-17 cells, migration speed was reduced only in the presence of tetracycline, whereas 15-20 cells and the B16F2 derivatives showed substantially reduced motility under non-induced conditions.
Control MDA-MB-231 cells migrated with high persistence (vectorial distance travelled/total distance traversed), mainly perpendicularly to the wound edge, but this was significantly reduced on short-term depletion of either the MRTFs or SRF (Fig. 3f ). In many cell lines, scratch-wounding induces repositioning of the microtubule organizing centre (MTOC) between the leading edge of the cell and the nucleus in cells bordering the wound, giving the cell an overall polarity that contributes to the directionality of movement 26 . In both MDA-MB-231 MRTF shRNA cell lines, the proportion of cells with a reoriented MTOC was significantly decreased, even in the absence of tetracycline, and MTOC orientation became effectively random on complete MRTF depletion ( Fig. 3g , Supplementary  Information, Fig. S3 ). Taken together these results implicate the MRTFs and SRF in control of cell adhesion and migration. 
MRTF-SRF signalling is required for invasion
Short term depletion of MRTFs or SRF using short interfering RNA (siRNA) oligonucleotides significantly impaired the ability of MDA-MB-231 cells to migrate through collagen-coated membranes towards serum-containing medium in a modified Boyden chamber assay ( Fig. 4a ). As stromal fibroblasts can have an important role in tumour invasiveness 27, 28 , we also tested the requirement for MRTF-SRF activity in an organotypic invasion model, in which tumour cells move through collagen gel along tracks generated by stromal carcinoma-associated fibroblasts (CAFs) 29 . Both MDA-MB-231 and B16F2 cells showed CAFdependent invasive behaviour, although B16F2 cells required greater numbers of CAFs to manifest invasion; in both cell lines invasive behaviour was MRTF-and SRF-dependent ( Fig. 4b ).
MRTFs are required for tumour cell motility in vivo
We next examined the role of MRTF-SRF signalling in tumour growth and motility in vivo. Depletion of MRTFs or SRF from MDA-MB-231 or B16F2 cells did not affect proliferation rate or promote apoptosis during culture ( Fig. 4c ; Supplementary Information, Fig. S1c, d) . Moreover, MRTF-or SRF-depletion neither increased anoikis when cells were grown in non-adherent conditions, nor sensitized cells to apoptosis when deprived of growth factors ( Supplementary Information, Fig. S1e , f). Consistent with these observations, subcutaneous implantation of MRTF-depleted MDA-MB-231 or B16F2 derivatives in appropriate host mice efficiently induced tumours that grew at rates comparable to control cell tumours (Fig. 4d ). The cells in the tumours remained proliferative, with MRTF RNA expression substantially suppressed ( Fig. 4e ; Supplementary Information, Fig. S4a ). MRTF proteins were present in both the nucleus and cytoplasm in MDA-MB-231 tumour sections, and were predominantly cytoplasmic in B16F2 tumours ( Supplementary  Information, Fig. S4b ). As metastasis is associated with cell motility in primary tumours 30, 31 , we used intravital imaging of tumour cells in situ 32 to investigate the motility of MRTF-depleted and control MDA-MB-231 cells stably expressing GFP or CFP ( Fig. 4f ; Supplementary Information, Movies 1-3). MRTF depletion led to an approximately twofold reduction in the number of motile cells per unit area of tumour ( Fig. 4g ). MRTF-depleted cells showed reduced motility in mixed tumours that also contained control cells, indicating that MRTF activity is required cell-autonomously for cell motility in vivo (Fig. 4g ).
MRTFs and SRF are required for experimental metastasis
To further investigate MRTF-SRF signalling in metastasis, we measured the ability of MDA-MB-231 or B16F2 cell derivatives to establish lung tumours following intravenous injection into the mouse tail vein. Large numbers of metastatic nodules were observed in animals injected with control MDA-MB-231 or B16F2 cell lines, whereas few or no tumours were detectable in animals injected with MRTF-depleted cells (Fig. 5a b; Supplementary Information, Fig. S4c ). Formation of tumours was very sensitive to MRTF depletion, with only the MDA-MB-231 15-17 cells showing residual colonization activity in the absence of doxycycline (data not shown).
To test whether the lack of tumour growth in these experiments reflects a failure of MRTF-depleted cells to colonize the lung, or the defective proliferation of established tumour cell colonies, we studied the initial fate of fluorescently labelled control and MRTF-depleted MDA-MB-231 cells, co-injected in equal numbers. Control and MRTF-depleted cells were present in the lung at a ratio of 1:1 at 2 h after injection, but by 24 h the ratio of control to MRTF-depleted cells had increased to 40:1 (Fig. 5c ). A similar result was obtained with MRTF-depleted MTLn3 cells, another breast tumour line that shows Rho-dependent metastatic spread 33 ( Fig. 5c; Supplementary Information, Fig. S4d ). MRTF depletion did not significantly increase the proportion of tumour cells newly arrived at the lung that were apoptotic, as judged by staining for activated caspase 3 (24.7 ± 3.7% control versus 19.3 ± 1.6%; mean ± s.e.m., MRTF-depleted; n = 3). These results strongly suggest that the failure of MRTF-depleted cells to form lung tumours arises because they are rapidly lost from the organ after their initial arrival (see Discussion).
We also assessed the role of SRF in the experimental metastasis assay. Lungs from mice injected with SRF-depleted MDA-MB-231 or B16F2 cells had few metastatic nodules, in contrast to abundant nodule formation observed in animals injected with control cells (Fig. 5d ). It is thus unlikely that lung colonization involves MRTF acting through transcription factors other than SRF, as suggested by a recent report 34 , or a cytoplasmic MRTF function resulting from their interaction with G-actin.
MRTF target genes are required for metastasis
The preceding experiments show that MRTF proteins and SRF are required for cytoskeletal dynamics and experimental metastasis in both MDA-MB-231 breast carcinoma and B16F2 melanoma cells. Reasoning that genes whose expression is MRTF-dependent in both cell lines would be candidates for genes mediating such shared MRTF-dependent cell behaviours, we used microarray analysis to compare the transcriptomes of control and MRTF-depleted MDA-MB-231 and B16F2 cells.
MRTF depletion affected expression of 4.9% and 1.4% of genes in MDA-MB-231 and B16F2 cells, respectively (significance cut-off 1.5fold; Supplementary Information, Table S1a, b). As cytochalasin D can directly activate the MRTFs 10,12 (Fig. 1d ), we also treated control or MRTF-depleted cells with cytochalasin D for 40 min and identified further candidate MRTF target genes as those whose cytochalasin D-induced levels were reduced by MRTF depletion. Cytochalasin D treatment increased expression of only 0.35% and 0.3% genes by more than 1.3-fold in MDA-MB-231 and B16F2 cells, respectively, and of these 80% and 55% were affected more than 1.5-fold by MRTF depletion ( Supplementary Information, Table S1c, d) . We compared the two datasets to identify MRTF-dependent genes shared between the two cell lines, defined as those where MRTF depletion affected either basal expression, cytochalasin D-induced expression or both in both lines, according to our significance criteria. Of 25 genes identified this way, expression of 16 was reduced after MRTF-depletion, consistent with MRTFs having a positive role in their expression. Of these, 13 were either functionally validated SRF target genes or contain a phylogenetically conserved SRF binding site within 5 kb of their transcription start site, suggesting that they are direct MRTF targets (Table 1 ). We validated the results using RT-PCR ( Supplementary Information, Fig. S5a ). As a first step in evaluating the potential contribution of SRF targets to invasion and metastasis, we focused on the cytoskeletal components MYH9 (NMHC-IIA) and MYL9 (MLC2). These proteins, which are components of the actomyosin contractile apparatus 35, 36 , have been implicated previously in invasive behaviour in tumour cells 5,37-39 . Depletion of MYH9 or MYL9 singly or in combination neither affected cell-cycle progression nor induced cell death in the two cell lines ( Supplementary  Information, Fig. S6 ). However, it significantly reduced invasiveness in the Boyden chamber and organotypic assays in MDA-MB-231 cells (Fig. 6a, b) , impaired short-term lung colonization by MDA-MB-231 cells (Fig. 6c ) and reduced formation of lung tumours by B16F2 cells in the experimental metastasis assay (Fig. 6d ). The requirement for MRTF activity in these processes thus reflects, at least in part, MRTF involvement in MYH9 and MYL9 transcription.
MRTF activity is limiting for experimental metastasis in B16F0 cells
To investigate whether elevation of MRTF activity can be sufficient to promote invasion and metastasis, we studied B16F0 cells, the less metastatic parent of the B16F2 cell line 4 . To potentiate MRTF activity in the absence of a signal, we expressed an activated form of MRTF-A, MAL-xxx, which does not bind actin 11, 12 . MAL-xxx markedly potentiated expression of the SRF reporter in B16F0 cells (Fig. 7a ) and increased expression of the endogenous Myl9, Myh9, Cyr61 and Tpm1 genes ( Fig. 7b ), but did not suppress anoikis or affect cell-cycle progression ( Supplementary Information, Fig. S1f and data not shown). Expressing MAL-xxx, which was predominantly nuclear, induced a strikingly spread morphology characterized by multiple, intensely staining paxillin foci, in contrast to untransfected cells, which were rounded with predominantly cytoplasmic paxillin (Fig. 7c) .MAL-xxx also significantly enhanced the ability of B16F0 cells to establish tumours in the lung colonization assay (Fig. 7d) . Thus, at least in certain cell contexts, potentiation of MRTF activity can be sufficient to promote the cytoskeletal activities required for lung colonization in experimental metastasis.
DISCUSSION
MRTF-SRF signalling is essential for the effective execution of a number of Rho-dependent cytoskeletal processes, including adhesion, spreading and motility. It is also required in experimental invasion and metastasis models. The MRTF-SRF system provides a means by which gene expression can be coordinated with changes in cellular G-actin levels induced by Rho signalling, and we propose that the pathway acts to generate conditions under which Rho-activated cytoskeletal events can occur effectively (Fig. 7e ). Rho-induced signalling to the nucleus thus has an essential indirect role that underpins the direct cytoplasmic role of Rho GTPase effectors in cytoskeletal remodelling. Our data suggest that the adhesion defects of SRF-null ES cells 14 and the impaired migration of SRF-null neurons in the mouse 15 are likely to reflect defects in the MRTF-mediated response to Rho signalling. Although cell motility is dependent on basal levels of Gα12/13dependent Rho-mDia signalling 25, 40 , MTOC reorganization and fibroblastled tumour cell invasion are Cdc42-and MRCK-dependent 26, 29 . As Rho, Rac and Cdc42 can all activate SRF through the actin-MRTF pathway 10, 41 , it is likely that the dependence of cytoskeletal behaviour on MRTFs reflects integration of signals from multiple Rho-family GTPases. It remains possible, however, that Rho-independent pathways are also involved.
Our data indicate that MRTF and SRF activity can facilitate at least two steps in the metastatic process and suggest that selection for increased Rho-actin-MRTF signalling is one of the pressures driving enhanced RhoC expression in metastatic human and mouse cancer models [4] [5] [6] [7] [8] . MRTF depletion did not affect growth of primary tumours, but reduced cell motility within the tumour. As previous studies have shown that motility correlates with intravasation 30, 31 , this suggests that MRTF is required for efficient exit from primary tumour sites. At later stages, MRTF and SRF activity is also required for efficient colonization of the lung from the bloodstream: MRTF-depleted cells can survive and arrive at the organ but fail to persist there. This may reflect defective adhesion to endothelial cells, impaired extravasation or defective adhesion or spreading within the lung, all of which may promote tumour cell elimination by apoptotic or other mechanisms. In culture, MRTF-or SRF-depletion did not sensitize cells to anoikis or increase apoptosis when cells were deprived of growth factors. Consistent with this, MRTF-depleted cells newly arrived at the lung did not show significantly increased apoptosis when compared with controls. Increased cell loss may therefore simply reflect their weakened attachment; however, more work is needed to fully characterize its kinetics and mechanism. Use of appropriate mouse cancer models, in conjunction with imaging of MRTF subcellular localization, MRTF-actin interaction and SRF reporter activity, will give insights into the stages of the metastatic process at which MRTF activity is rate-limiting for different tumours.
The effects of MRTF depletion are strikingly similar in B16F2 melanoma and MDA-MB-231 breast carcinoma cells, consistent with MRTFs acting through a shared set of gene targets. The MRTFs seem to act redundantly, at least as far as SRF reporter activation is concerned. Moreover, the similarity between the cytoskeletal phenotypes of MRTFand SRF-depleted cells suggests that they reflect SRF-mediated action of the MRTFs. Indeed, 13 of the 16 genes that are positively regulated by MRTFs in the two cell lines are known or putative SRF targets, suggesting that they are also direct MRTF targets. We therefore think it unlikely that our results reflect MRTF signalling through Smads to EMT 34 ; indeed, MRTF depletion did not affect expression of markers or regulators of mesenchymal invasive gene expression in MDA-MB-231 or B16F2 cells ( Supplementary Information, Fig. S5b ).
Genomic studies indicate that SRF is a global regulator of cytoskeletal gene expression 13 , and many of its cytoskeletal targets are controlled through Rho-actin signalling through the MRTFs [41] [42] [43] [44] . Some encode cytoskeletal components involved in actomyosin-based contractility, including non-muscle myosin heavy chain (MYH9/NMHC-IIA) and its regulatory light chain (MYL9/MLC2), which have both previously been implicated in tumour cell invasive behaviour, and which are targets of the Rho effector ROCK 5,37-39 . Our data indicate that the MRTF/ SRF-dependence of cytoskeletal events and experimental metastasis reflects, at least in part, a requirement for sufficient basal expression of these genes (Fig. 7e) . The other positively regulated MRTF targets shared by MDA-MB-231 and B16F2 cells, which appear surprisingly few in number, may also have important roles: for example, the CCN proteins Cyr61 and CTGF seem to have pro-and anti-invasive roles in breast cancer 45 , whereas Fos has been implicated in skin tumour progression 46 . A number of MRTF targets are not affected at the basal level but are susceptible to acute activation of the MRTF-SRF pathway. Such activation is likely to occur through Rho signalling during particularly dynamic periods of cytoskeletal remodelling, such as exit from the primary tumour and extravasation at secondary sites: in addition to extracellular stimuli, Rho signalling is known to be activated by mechanical stress 1 , which can induce MRTF nuclear accumulation [41] [42] [43] [44] (Fig. 7e) . Intriguingly, MRTF depletion increases expression of nine genes in both lines; however, the mechanism underlying this, and the functional role of these genes, awaits elucidation.
At least in certain cell contexts, activity of the MRTF-SRF pathway can be limiting, as expression of constitutively active MRTF-A can promote cell spreading and potentiation of lung colonization by the poorly metastatic B16F0 cells; further analysis of MRTF expression and activity during tumour progression is therefore warranted. MRTF proteins are substantially nuclear in both MDA-MB-231 and MTLn3 breast tumours, and MRTF proteins are also nuclear in a subset of spontaneous breast tumours (data not shown); however, MRTFs are predominantly cytoplasmic in B16F2 cells, so nuclear MRTF localization is not indicative of metastatic capability per se. Indeed, although nuclear localization of MRTFs is required for their function as transcriptional activators, it is not necessarily sufficient for maximal activity, which requires their dissociation from actin 12 . It will be interesting to assess systematically how MRTF expression, subcellular localization and activity correlate with tumour invasiveness and progression.
METHODS
Cell lines and cell culture.
Human MDA-MB-231 breast carcinoma cells and mouse B16F0 and B16F2 melanoma cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS), and MTLn3 rat breast carcinoma cells in αMEM containing 5% FCS. For in vivo tracking, pooled MDA-MB-231 cell clones stably expressing GFP or CFP from expression plasmids (Clontech) were recovered by FACS and expanded in neomycin (100 µg ml -1 ). GFP-and Cherryexpressing MTLn3 cells have been described previously 47 . Growth curves were obtained by daily counting of cells growing in 10% serum and compared by 2-way ANOVA. The cell-cycle was analysed using standard methods (see Supplementary  Information) . MDA-MB-231 and B16-F2 derivatives expressing Tet repressor were constructed using pcDNA6/TR (Invitrogen), selecting for blasticidin resistance (5 μg ml -1 ). Clones that showed effective Tet-operator-luciferase reporter activation were used to generate shRNA cell lines using pTER-shRNA plasmids 48 (see Supplementary Information Methods), selecting for zeocin resistance (200 μg ml -1 ). Appropriate MDA-MB-231 and B16F2 shRNA clones were selected for further use following immunoblotting and SRF reporter analysis.
Transfections, reporter assays, siRNA treatments and immunofluorescence.
Expression plasmids for MAL/MRTF-A derivatives, C3 transferase, actin R62D and activated Rho GTPases have been described 10, 11 . For reporter assays, cells in 24-well dishes were transfected with SRF (p3DA-luc) and control (ptk-RL) reporters and analysed as described previously 1011,12 . For siRNA sequences, see Supplementary Information Methods. For short-term depletions, MDA-MB-231 or B16F2 cells were transfected with siRNA oligonucleotides (190 pmol) using Lipofectamine 2000 (Invitrogen; MDA-MB-231) and Plus Reagent (B16F2; Invitrogen).
Whole-cell extract preparation, immunoblotting and immunofluorescence were performed using standard techniques. F-actin was detected with FITCphalloidin (Invitrogen) and nuclei were visualized using DAPI or PI. For antibodies, see Supplementary Information Methods).
Adhesion-spreading assay. Cells detached using PBS-EDTA (1 mM) were plated in dishes coated with fibronectin (10 μg ml -1 ; Sigma) or collagen I (50 μg ml -1 ; BD Biosciences), and later processed for fluorescence microscopy or quantitative adhesion assay using BCECF according to the manufacturer's protocol (Invitrogen).
Scratch-wound assay. Confluent cells previously induced or not with tetracycline were scratch-wounded with a 20 μl pipette tip. Cell migration was monitored using time-lapse video microscopy every 5 min or 30 min for 48 h after scratching, using a low-light inverted Zeiss microscope. Cells at the leading edge of the scratch were tracked using Tracker software. Mean speeds were calculated over the recording time for each cell; persistence was measured during successive 50-min windows for each cell. Migration speed and persistence were evaluated using an algorithm implemented in Mathematica software (Wolfram Research), with hierarchical ANOVA analysis taking into account the nested data structure.
Transwell and organotypic invasion assays. Polycarbonate transwells (8-μm pore size) were coated with 3 mm deep 2 mg ml -1 collagen gel in serum-free medium containing 20 mM Hepes, and set for 1 h. Tetracycline-treated cells were allowed to attach for 2-3 h to the underside of the chamber, and then whole medium was added to the upper compartment. Cells were allowed to migrate into the collagen matrix for 16 h, fixed, stained with PI and z sections taken by confocal microscopy. Invasion index was defined as the percentage of migrated cells per initially attached cells.
Organotypic invasion assays through matrix containing CAFs (0.5 × 10 6 ml -1 for MDA-MB-231; 1.2 × 10 6 ml -1 for B16F2) were as described previously 29 (see Supplementary Information Methods). Invasion index was calculated as 1-(noninvading area/total area).
Tumour growth and metastatic lung assay. Animal experimentation was carried out under the UK Home Office Project licence PPL70/5670. Animals were maintained in SPF conditions in the CRUK Biological Resources Unit.
For xenografts, 2 × 10 6 MDA-MB-231 or 0.2 × 10 6 B16F2 cells were injected subcutaneously into the fat pad of female nude mice or the flank of C57BL/6 mice respectively, and animals were maintained on doxycycline (2 mg ml -1 in water). RNA was extracted using the RNeasy mini-column (Qiagen). Frozen tumour sections were used for anti-Ki-67 histochemistry (VP-K451, Vector laboratories).
For experimental metastasis assays, cells were injected into the tail vein of the appropriate host (1-2 × 10 6 MDA-MB-231 or 0.3 × 10 6 B16F2 stable shRNA derivatives; 0.75 × 10 6 or 0.9 × 10 6 transiently siRNA-transfected B16F2 or B16F0 cells, respectively). Lungs were dissected 12-20 weeks (MDA-MB-231) or 9-14 days (B16F2, B16F0) later, rinsed in PBS and fixed in 10% neutral-buffered formalin solution. MDA-MB-231 lungs were paraffin-embedded, sectioned (4-μm thickness, 5 levels, 100-μm intervals), stained with haematoxylin and eosin, and metastatic nodules counted. B16F2 lungs were whitened using Fekete's solution (70% ethanol, 8% formaldehyde, 4% acetic acid) and surface metastatic lung nodules counted macroscopically. Results with transiently transfected cells and stable cell lines were comparable, as MRTF-depletion affects an early step in lung colonization.
Short-term lung colonization assays used fluorescently labelled MDA-MB-231 and Mtln3 cell derivatives, transfected with siRNA 24 h before use. MRTF-depleted and control cells (0.75 × 10 6 each), were injected into the tail vein of nude mice, which were killed 2 h or 24 h later. Fluorescently labelled cells in the lung were counted microscopically. MYL9-and MYH9-depleted cells were injected separately and the number of fluorescent cells was normalized to the total lung surface examined. Apoptotic tumour cells were detected by staining paraffin-embedded lung sections with anti-GFP (AB6673, Abcam) and anti-caspase 3 (EF835, R&D) antibodies.
Intravital imaging. Female SCID mice (5-6 weeks old) were injected in the mammary fat pad with 10 6 tumour cells and maintained on doxycycline (2 mg ml -1 ). When tumours reached a diameter of 5-7 mm (at 21-26 days), mice were anaesthetized and the tumour exposed 32 . Chameleon Coherent Ti-Sapphire laser was tuned to 870 nm for EGFP excitation and to 850 nm for ECFP excitation or simultaneous ECFP and EGFP excitation. CFP, GFP and collagen were distinguished as described previously, and tissue architecture and host cells assessed using a reflectance image collected using a 633 nm laser 32 . Typically, four different areas, 2-3 sections per area, were imaged for 20-30 min in each tumour (4-6 tumours per animal). Motile cells that remained visible in the same confocal section for several minutes were counted and normalized to the total area of tumour cells in the section, as determined by ECFP or EGFP fluorescence. Cells that moved between sections were not analysed.
Microarray procedures and analysis. Total RNA was prepared using Trizol (Invitrogen) followed by RNeasy purification and cRNA probe generation (Affymetrix GeneChip protocol). MDA-MB-231 clones grown with tetracycline for 7 days were induced by cytochalasin D (5 μM) for 40 min in two independent cell-induction experiments. B16F2 cells were transfected with control or mrtfa/b siRNA oligonucleotides, with a 40-min cytochalasin D treatment (5 μM) 48 h later, in 3 independent experiments. Microarray analysis used U133Plus 2.0 GeneChips (54675 probe-sets, targeting 24317 unique refseq mRNA records, 21008 unique Unigene IDs) and mouse MOE430 2.0 GeneChips (45101 probesets, targeting 42945 unique refseq mRNA records, 22640 unique Unigene IDs). Comparative analyses were carried out using the empirical Bayes t-test provided within the 'limma' package to detect differential expression 49 : gene lists were subjected to a false discovery threshold of 0.001 before being filtered by fold change. Genes whose expression was altered by more than 1.5-fold on depletion were defined as MRTF-dependent. Cytochalasin D-inducible genes were defined as those whose expression changed by more than 1.3-fold upon stimulation; genes whose cytochalasin D-induced level was reduced by more than 1.5-fold upon MRTF-depletion were defined as MRTF-dependent. Where multiple probes were interrograted for a gene, the effects of MRTF depletion were taken as the average of the effects for each probe. For induction by cytochalasin D, fold induction was taken as the average of the fold inductions for each probe. Only probes covering the same transcripts were included in the analysis. Quantitative PCR (Q-PCR) validation was performed using SYBR Green-based real-time PCR (Invitrogen) as described previously 12 (see Supplementary Information for primer details). For Annexin/PI staining samples were resuspended in 0.5ml calcium-containing Annexin binding buffer (Pharmingen). 5µl of annexin-FITC were added and samples left for 15 minutes at room temperature in the dark. 50µl 50 µg/ml PI were added immediately before running on the FACSCalibur. Annexin-FITC fluorescence was measured using a 530nm bandpass filter and PI fluorescence using a 670nm longpass filter. At least 20,000 events were acquired from each sample and data were analysed using FlowJo software. Events were scored as early apoptotic if they were annexin-positive and PI-negative; late apoptotic and necrotic cells were annexin-and PI-positive. For analysis of anoikis, cells were seeded onto 24-well ultra-low attachment plates (Corning). After 24 or 48hrs, cells were analysed by PI and Annexin staining as above.
Notes
(i) Data were condensed as follows in order to make the dataset comparison shown in Figure 6A . Where multiple probes were interrograted for a gene, the effects of MRTF depletion were taken as the average of the effects for each probe; for induction by CD, fold induction was taken as the average of the fold inductions for each probe. Only probes covering the same transcripts were included in the analysis. (iv) A significant number of genes display a reduction in transcript level following 40min CD treatmen. Strikingly, for the majority of these genes this behaviour is also MRTF-dependent: in MRTF-depleted cells they show become essentially insensitive to CD-treatment. We are currently investigating the basis for this.
(v) Some CD-inducible genes (eg Jun, KLF4 in B16F2 cells; see also Figure 6A) show increased basal and induced expression upon MRTF-depletion, but show no change in sensitivity to CD.
